Robeco Institutional Asset Management B.V. lowered its position in shares of AptarGroup, Inc. (NYSE:ATR – Free Report) by 2.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 181,709 shares of the industrial products company’s stock after selling 4,780 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.27% of AptarGroup worth $28,546,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in ATR. Mackenzie Financial Corp raised its holdings in AptarGroup by 25.6% during the 2nd quarter. Mackenzie Financial Corp now owns 4,710 shares of the industrial products company’s stock worth $663,000 after purchasing an additional 960 shares during the last quarter. Creative Planning grew its position in shares of AptarGroup by 13.9% during the 2nd quarter. Creative Planning now owns 3,422 shares of the industrial products company’s stock worth $482,000 after buying an additional 417 shares during the period. Sanctuary Advisors LLC bought a new stake in shares of AptarGroup during the second quarter worth approximately $1,087,000. Canandaigua National Bank & Trust Co. acquired a new position in AptarGroup in the third quarter valued at approximately $234,000. Finally, Handelsbanken Fonder AB boosted its stake in AptarGroup by 182.1% in the third quarter. Handelsbanken Fonder AB now owns 538,830 shares of the industrial products company’s stock valued at $86,315,000 after acquiring an additional 347,800 shares during the last quarter. Institutional investors and hedge funds own 88.52% of the company’s stock.
Insider Transactions at AptarGroup
In related news, EVP Kimberly Chainey sold 964 shares of the company’s stock in a transaction on Friday, November 15th. The shares were sold at an average price of $168.83, for a total value of $162,752.12. Following the completion of the transaction, the executive vice president now directly owns 7,848 shares of the company’s stock, valued at approximately $1,324,977.84. This represents a 10.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.00% of the stock is owned by insiders.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on ATR
AptarGroup Trading Up 0.7 %
NYSE:ATR opened at $158.18 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.15. The business’s 50-day simple moving average is $162.19 and its 200-day simple moving average is $158.46. AptarGroup, Inc. has a fifty-two week low of $128.05 and a fifty-two week high of $178.03. The stock has a market capitalization of $10.53 billion, a PE ratio of 31.76, a price-to-earnings-growth ratio of 2.62 and a beta of 0.59.
AptarGroup declared that its board has initiated a share buyback program on Thursday, October 10th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the industrial products company to repurchase up to 4.7% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board believes its shares are undervalued.
AptarGroup Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 5th will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 1.14%. The ex-dividend date of this dividend is Wednesday, February 5th. AptarGroup’s dividend payout ratio (DPR) is presently 36.14%.
AptarGroup Profile
AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.
See Also
- Five stocks we like better than AptarGroup
- Top Biotech Stocks: Exploring Innovation Opportunities
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Invest in Biotech Stocks
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is an Earnings Surprise?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding ATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AptarGroup, Inc. (NYSE:ATR – Free Report).
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.